Medication-Related Cognitive Impairments in the Elderly
- Tue, 11/11/08 - 11:04am
- 0 Comments
- 5556 reads
Pages 11 - 14
Author Affiliations:
Dr. Iwuagwu is Assistant Professor of Medicine, and
Dr. Steiner is Assistant Professor, College of Medicine, University of Toledo, Health Sciences Campus, Toledo, OH; and Dr. Raji is Associate Professor, Director of
Memory Loss Clinic and Medical Director of the Acute Care for the Elderly (ACE) Unit, Sealy Center on Aging, Department of Internal Medicine, University of Texas Medical Branch, Galveston.
Dr. Lantz is Chief of Geriatric Psychiatry, Beth Israel Medical Center, First Ave @ 16th Street #6K40, New York, NY 10003; (212) 420-2457; fax: (212) 844-7659;
e-mail: mlantz@chpnet.org.
1. Larsen PD, Martin JL. Polypharmacy and elderly patients. AORN J 1999;69(3):619-622,625,627-628.
2. Stratton MA, Salinas RC. Medication management in the elderly. J Okla State Med Assoc 2003;96(3):116-122.
3. Merck Company Foundation. The State of Health and Aging in America 2007. Centers for Disease Control Website. www.cdc.gov/Aging/pdf/saha_2007.pdf. Accessed July 30, 2008.
4. Weytingh MD, Bossuyt PM, van Crevel H. Reversible dementia: More than 10 percent or less than 1 percent? A quantitative review. J Neurol 1995;242:466-471.
5. Walstra GJ, Teunisse S, van Gool WA, van Crevel H. Reversible dementia in elderly patients referred to a memory clinic. J Neurol 1997;244:17-22.
6. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157(14):1531-1536.
7. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991;151(9):1825-1832.
8. Fox GN, Moawad N. UpToDate: A comprehensive clinical database. J Fam Pract 2003;52(9):706-710.
9. Clarfield AM. The reversible dementias: Do they reverse? Ann Intern Med 1988;109:476-486.
10. Larson EB, Reifler BV, Sumi SM, et al. Features of potentially reversible dementia in elderly outpatients. West J Med 1986;145(4):488-492.
11. Hanlon JT, Artz MB, Pieper CF, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004;38(1):9-14.
12. Schmader KE, Hanlon JT, Landsman PB, et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997;31(5):529-533.
13. Raji MA, Ostir GV, Markides KS, et al. Potentially inappropriate medication use by elderly Mexican Americans. Ann Pharmacother 2003;37:1197-1202.
14. Aparasu RR, Fliginger SE Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother 1997;31:823-829.
15. Sloane P, Zimmerman S, Brown L, et al. Inappropriate medication prescribing in residential care/assisted living facilities. J Am Geriatr Soc 2002;50:1001-1011.
16. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: Findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001;286:2823-2829.
17. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts [published correction appears in Arch Intern Med 2004;164(3):298]. Arch Intern Med 2003;163(22):2716-2724.
18. Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003;44(Suppl 4):21-29.
19. Vermeulen J, Aldenkamp AP. Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research. Epilepsy Res 1995;22:65-95.
20. Sands L, Katz IR, DiFilippo S, et al. Identification of drug-related cognitive impairment in older individuals. Challenge studies with diphenhydramine. Am J Geriatr Psychiatry 1997;5:156-166.
21. Katz IR, Sands LP, Bilker W, et al. Identification of medications that cause cognitive impairment in older people: The case of oxybutynin chloride. J Am Geriatr Soc 1998;46:8-13.
22. Raji MA, Barnum PD, Freeman J, Markowitz AB. Mirtazapine for depression and comorbidities in older patients with cancer. Ann Pharmacother 2007;41(9):1548-1549. Published Online: July 10, 2007.
23. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: The prescribing cascade. BMJ 1997;315(7115):1096-1099.
24. Gill SS, Mamdani M, Naglie G, et al. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med 2005;165(7):808-813.
Post new comment